Downregulation of vascular endothelial growth factor and integrinβ3 by endostatin in a mouse model of retinal neovascularization
- 31 January 2006
- journal article
- Published by Elsevier in Experimental Eye Research
- Vol. 82 (1) , 74-80
- https://doi.org/10.1016/j.exer.2005.05.005
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Inhibition of Retinal Neovascularization by Intraocular Viral-Mediated Delivery of Anti-angiogenic AgentsMolecular Therapy, 2002
- Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2001
- αvβ3 and αvβ5 Integrin Expression in MeningiomasNeurosurgery, 2000
- RGD-Dependent Vacuolation and Lumen Formation Observed during Endothelial Cell Morphogenesis in Three-Dimensional Fibrin Matrices Involves the αvβ3 and α5β1 IntegrinsThe American Journal of Pathology, 2000
- Inhibition of Vascular Endothelial Growth Factor Prevents Retinal Ischemia—Associated Iris Neovascularization in a Nonhuman PrimateArchives of Ophthalmology (1950), 1996
- Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.Proceedings of the National Academy of Sciences, 1995
- Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurityNature Medicine, 1995
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic RetinopathyAmerican Journal of Ophthalmology, 1994
- Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.Molecular Biology of the Cell, 1992